The Chinese Multi-provincial Cohort Study, which involved 643 participants free of cardiovascular disease at baseline showed that PCSK9 levels are associated with the progression of atherosclerosis, as reflected by the total plaque area, independently of plasma LDL-C concentrations [58]. Here, PCSK9 is linked to atherosclerosis.